Descrizione Clinica
Apromised
OTHER PRODUCTS
Description
Vanilla flavoured aprothetic cookies. With eulcorant.
Indicated for the dietary management of chronic kidney failure (IRC). Indicated for the dietary management of Fenilchetonuria. Indicated for the dietary management of Parkinson's disease (in Levodopa therapy).
The product, for its composition, is suitable for all three categories of patients. In particular: the product has been specially formulated with reduced protein content, sodium, phosphorus and potassium ingredients to meet the nutritional needs of patients suffering from chronic kidney failure; the composition of the product has, in addition, a reduced contribution of phenylalanine for the dietary management of the subjects under conditions of Fenilchetonuria.
Moreover, the product, thanks to a limited protein content, is also suitable for the dietary management of patients suffering from Parkinson's disease in treatment with Levodopa, as it does not interfere in the absorption of this amino acid.
For the patient in Levodopa therapy, the degree of disfaction and possible malnutrition problems must be assessed due to defects that may arise under protein restriction.
Ingredients
Corn starch; sweetener: maltitol; vegetable fat (karitè, coconut), sunflower seed oil, corn flour, vegetable fiber (cicory inulin); thickener: xanthan gum; vanilla aroma 0.6%, sugar cane fiber; emulsifier: sunflower lecitines; rising agent: ammonium carbonates.
Nutritional characteristics
Warnings
The product must be used under medical control and cannot be used as the only source of nutrition.
Contains sweeteners: excessive consumption can have laxative effects.
Conservation
Store in a cool and dry place away from heat sources and sunlight.
Format
120 g.
Cod. MANUFACTURE FROM MATERIALS OF ANY HEADING
Vanilla flavoured aprothetic cookies. With eulcorant.
Indicated for the dietary management of chronic kidney failure (IRC). Indicated for the dietary management of Fenilchetonuria. Indicated for the dietary management of Parkinson's disease (in Levodopa therapy).
The product, for its composition, is suitable for all three categories of patients. In particular: the product has been specially formulated with reduced protein content, sodium, phosphorus and potassium ingredients to meet the nutritional needs of patients suffering from chronic kidney failure; the composition of the product has, in addition, a reduced contribution of phenylalanine for the dietary management of the subjects under conditions of Fenilchetonuria.
Moreover, the product, thanks to a limited protein content, is also suitable for the dietary management of patients suffering from Parkinson's disease in treatment with Levodopa, as it does not interfere in the absorption of this amino acid.
For the patient in Levodopa therapy, the degree of disfaction and possible malnutrition problems must be assessed due to defects that may arise under protein restriction.
Ingredients
Corn starch; sweetener: maltitol; vegetable fat (karitè, coconut), sunflower seed oil, corn flour, vegetable fiber (cicory inulin); thickener: xanthan gum; vanilla aroma 0.6%, sugar cane fiber; emulsifier: sunflower lecitines; rising agent: ammonium carbonates.
Nutritional characteristics
| Average values | for 100 g |
| Energy | 2.067 kJ/495 kcal |
| Fats of which saturated fatty acids | 26 g 11 g |
| Carbohydrate of which sugar of which polyols | 70 g 1.6 g 16 g |
| Fibre | 1,1 g |
| Protein of which phenylalanine | 0,6 g 25.4 mg |
| Rooms of which sodium | 0.03 g 11.2 mg |
| Phosphorus | 18.3 mg |
| Potassium | 13.7 mg |
Warnings
The product must be used under medical control and cannot be used as the only source of nutrition.
Contains sweeteners: excessive consumption can have laxative effects.
Conservation
Store in a cool and dry place away from heat sources and sunlight.
Format
120 g.
Cod. MANUFACTURE FROM MATERIALS OF ANY HEADING
